BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27297279)

  • 21. Unilateral livedoid vasculopathy associated with involutional phase of cutaneous infantile hemangioma: the connection to coagulation disorders.
    Criado PR; Alavi A; Halpern I; Sotto MN; Kirsner RS
    Int J Low Extrem Wounds; 2013 Dec; 12(4):306-9. PubMed ID: 24043683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of intravenous immunoglobulins in livedoid vasculopathy: long-term follow-up of 11 patients.
    Monshi B; Posch C; Vujic I; Sesti A; Sobotka S; Rappersberger K
    J Am Acad Dermatol; 2014 Oct; 71(4):738-44. PubMed ID: 25022849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrophie blanche with onset in childhood.
    Suarez SM; Paller AS
    J Pediatr; 1993 Nov; 123(5):753-5. PubMed ID: 8229486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Punch grafting for the treatment of ulcerated atrophie blanche.
    Orbea Sopeña A; Conde Montero E
    Phlebology; 2023 Dec; 38(10):695-697. PubMed ID: 37624370
    [No Abstract]   [Full Text] [Related]  

  • 25. Adalimumab in the Treatment of Recalcitrant Livedoid Vasculopathy.
    Bhatt DM; Bhamburkar S; Madke B; Jangid SD; Khan A
    Cureus; 2023 Dec; 15(12):e50053. PubMed ID: 38186477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Livedoid vasculopathy - current aspects of diagnosis and treatment of cutaneous infarction.
    Kerk N; Goerge T
    J Dtsch Dermatol Ges; 2013 May; 11(5):407-10. PubMed ID: 23437985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Widespread livedoid vasculopathy.
    Marzano AV; Vanotti M; Alessi E
    Acta Derm Venereol; 2003; 83(6):457-60. PubMed ID: 14690343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome?
    Acland KM; Darvay A; Wakelin SH; Russell-Jones R
    Br J Dermatol; 1999 Jan; 140(1):131-5. PubMed ID: 10215783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dermoscopic features of livedoid vasculopathy.
    Hu SC; Chen GS; Lin CL; Cheng YC; Lin YS
    Medicine (Baltimore); 2017 Mar; 96(11):e6284. PubMed ID: 28296736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Liveoid vasculopathy with combined thrombophilia: efficacy of iloprost].
    Magy N; Algros MP; Racadot E; Gil H; Kantelip B; Dupond JL
    Rev Med Interne; 2002 Jun; 23(6):554-7. PubMed ID: 12108180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin.
    Davis MD; Wysokinski WE
    J Am Acad Dermatol; 2008 Mar; 58(3):512-5. PubMed ID: 18280355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Livedoid vasculopathy associated with heterozygous protein C deficiency.
    Boyvat A; Kundakçi N; Babikir MO; Gürgey E
    Br J Dermatol; 2000 Oct; 143(4):840-2. PubMed ID: 11069468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of an anti-TNF-alpha agent in refractory livedoid vasculopathy: a retrospective analysis.
    Gao Y; Jin H
    J Dermatolog Treat; 2022 Feb; 33(1):178-183. PubMed ID: 32116074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban.
    Franco Marques G; Criado PR; Alves Batista Morita TC; Cajas García MS
    Int J Dermatol; 2018 Jun; 57(6):732-741. PubMed ID: 29663354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical, Laboratory, Histopathological and Therapeutic Profile of Livedoid Vasculopathy: A Case Series of 17 Patients.
    Shah SR; Vyas HR; Doshi YJ; Shah BJ
    Indian Dermatol Online J; 2022; 13(6):771-774. PubMed ID: 36386750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Livedoid vasculopathy. Pathogenesis, diagnosis and treatment of cutaneous infarction].
    Goerge T
    Hautarzt; 2011 Aug; 62(8):627-34; quiz 635. PubMed ID: 21786003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome.
    Cardoso R; Gonçalo M; Tellechea O; Maia R; Borges C; Silva JA; Figueiredo A
    Int J Dermatol; 2007 Apr; 46(4):431-4. PubMed ID: 17442092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Livedoid Vasculopathy with Hyperhomocysteinemia Responding to Hyperbaric Oxygen Therapy.
    Ray R; Sharma A; Vasudevan B; Sridhar J; Deo R; Mohanty CS
    Indian J Dermatol; 2015; 60(5):524. PubMed ID: 26538741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Livedoid vasculopathy: long-term follow-up results following hyperbaric oxygen therapy.
    Juan WH; Chan YS; Lee JC; Yang LC; Hong HS; Yang CH
    Br J Dermatol; 2006 Feb; 154(2):251-5. PubMed ID: 16433793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [What was your diagnosis at first glance... livedoid vasculopathy].
    Hirschel V
    Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1439. PubMed ID: 23986912
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.